The relation of vascular endothelial growth factor (VEGF) gene polymorphisms on VEGF levels and the risk of vasoocclusive crisis in sickle cell disease
- 30 August 2012
- journal article
- Published by Wiley in European Journal of Haematology
- Vol. 89 (5), 403-409
- https://doi.org/10.1111/ejh.12003
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Update on Pain Management in Sickle Cell DiseaseHemoglobin, 2011
- Sickle-cell diseaseThe Lancet, 2010
- Modifier genes in Mendelian disorders: the example of hemoglobin disordersAnnals of the New York Academy of Sciences, 2010
- The VEGF family in cancer and antibody-based strategies for their inhibitionmAbs, 2010
- A primary care provider’s guide to preventive and acute care management of adults and children with sickle cell diseaseJournal of the American Academy of Nurse Practitioners, 2009
- Vascular Endothelial Growth FactorsJournal of the American College of Cardiology, 2007
- Vascular Endothelial Growth Factor (VEGF)-Receptor2: Its Biological Functions, Major Signaling Pathway, and Specific Ligand VEGF-EEndothelium, 2006
- Sickle blood contains tissue factor–positive microparticles derived from endothelial cells and monocytesBlood, 2003
- Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusionBlood, 2000
- Red blood cell changes during the evolution of the sickle cell painful crisisBlood, 1992